Evidence map›Paper›PMID 20008141›Full record

ArticleThe American journal of pathology2010

Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations.

Miguel A Gama Sosa, Rita De Gasperi, Anne B Rocher, Athena Ching-Jung Wang, William G M Janssen, Tony Flores, Gissel M Perez, James Schmeidler, Dara L Dickstein, Patrick R Hof and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Glycocalyx and basal lamina in neurological disorders.Matrix biology : journal of the International Society for Matrix Biology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Basal lamina changes in neurodegenerative disorders.Molecular neurodegeneration · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Miguel A Gama SosaResearch and Development, James J. Peters Department of Veterans Affairs Medical Center, Bronx, New York, USA.
Rita De Gasperi
Anne B Rocher
Athena Ching-Jung Wang
William G M Janssen
Tony Flores
Gissel M Perez
James Schmeidler
Dara L Dickstein
Patrick R Hof
Gregory A Elder
Icahn School of Medicine at Mount Sinai · USJames J. Peters VA Medical Center · USImaging Center · USBoston University · US

Funding

VESICULAR LOCALIZATION AND FUNCTION OF PRESENILIN 1 FRAGMENTP50AG005138 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SCHIMMING, CORBETT · 1985 to 2019
$37.9M
QUANTITATIVE ANALYSIS OF MICROVASCULAR CHANGES IN THE AGING BRAINP01AG002219 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI HAROUTUNIAN, VAHRAM · 1985 to 2009
$19.2M
STUDIES OF CHOLINERGIC SYSTEMS AND AMYLOIDOGENESISP01AG010491 · NIA · THOMAS JEFFERSON UNIVERSITY · PI GANDY, SAMUEL E. · 1991 to 2009
$11.1M
Role of Presenilin-1 in Neural Injury and RepairR01AG020139 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI ELDER, GREGORY A · 2002 to 2005
$1.0M
Presenilin-1 as an Hypoxia SensorR21AG029361 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ELDER, GREGORY A. · 2007 to 2008
$286k
Mechanisms Underlying the Vascular Pathology of Alzheimer's DiseaseI01BX000342 · VA · JAMES J PETERS VA MEDICAL CENTER · PI ELDER, GREGORY A. · 2009 to 2012
–
BLRD VA I01 BX000342NIA NIH HHS AG010491NIA NIH HHS AG02219NIA NIH HHS AG029361NIA NIH HHS AG05138NIA NIH HHS AG20139NIA NIH HHS P01 AG002219NIA NIH HHS P01 AG010491NIA NIH HHS P50 AG005138NIA NIH HHS R01 AG020139NIA NIH HHS R21 AG029361
6 · The paper itself

Abstract

Mutations in the presenilin 1 (PS1) gene are the most commonly recognized cause of familial Alzheimer's disease (FAD). Besides senile plaques, neurofibrillary tangles, and neuronal loss, Alzheimer's disease (AD) is also accompanied by vascular pathology. Here we describe an age-related vascular pathology in two lines of PS1 FAD-mutant transgenic mice that mimics many features of the vascular pathology seen in AD. The pathology was especially prominent in the microvasculature whose vessels became thinned and irregular with the appearance of many abnormally looped vessels as well as string vessels. Stereologic assessments revealed a reduction of the microvasculature in the hippocampus that was accompanied by hippocampal atrophy. The vascular changes were not congophilic. Yet, despite the lack of congophilia, penetrating vessels at the cortical surface were often abnormal morphologically and microhemorrhages sometimes occurred. Altered immunostaining of blood vessels with basement membrane-associated antigens was an early feature of the microangiopathy and was associated with thickening of the vascular basal laminae and endothelial cell alterations that were visible ultrastructurally. Interestingly, although the FAD-mutant transgene was expressed in neurons in both lines of mice, there was no detectable expression in vascular endothelial cells or glial cells. These studies thus have implications for the role of neuronal to vascular signaling in the pathogenesis of the vascular pathology associated with AD.

Indexed as

AgingAlzheimer DiseaseAnimalsAtrophyBasement MembraneBlood VesselsBrainChromosomes, Artificial, P1 BacteriophageDendritesExtracellular Matrix ProteinsHumansMiceMice, Inbred C57BLMice, TransgenicMicrovesselsMutant ProteinsExtracellular Matrix ProteinsMutant ProteinsPresenilin-1

Identifiers

PMID20008141
PMCPMC2797896
OpenAlexW2055083885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.